Obesity and insulin resistance are associated with classic and new cardiovascular risk factors, such as inflammatory markers and adipocytokines. The aim of this study was to examine whether weight reduction could change visfatin serum concentrations in obese patients.
Institute of Endocrinology and Nutrition, University of Valladolid, and Clinical Nutrition Research Unit (RD056/0013), Hospital Rio Hortega, Valladolid, Spain. dadluis@yahoo.es
